Diabetes Mellitus Complicating Pregnancy

Marking B. Landon Medico , in Gabbe's Obstetrics: Normal and Problem Pregnancies , 2021

Early Screening for Overt Diabetes and Detection of Gestational Diabetes Mellitus

The frequency of diabetes complicating pregnancy has generally been estimated to be as loftier every bit 6% to 7%, with approximately ninety% of these cases representing women with GDM. 43 Using a pregnancy chance-cess monitoring organisation between 2007 and 2010, DeSisto and colleagues 43 confirmed that the prevalence of GDM is ascension in the U.s.a. and may now be as high as 9.two%. The increasing frequency of GDM tin can be attributed to the worldwide obesity epidemic, likewise the introduction of less stringent criteria for the diagnosis now being adjusted by some institutions. An increased prevalence of GDM is found in women of ethnic groups that take high frequencies of type 2 diabetes. These include women of Hispanic, African, Native American, Asian, and Pacific Island ancestry. Women with GDM represent a group with significant risk for developing glucose intolerance later in life. O'Sullivan projected that 50% of women with GDM would become diabetic in follow-up at 22 to 28 years. Kjos and colleagues reported that 60% of Latina women will develop type 2 diabetes, and this level of gamble may actually be manifest by five years after the GDM index pregnancy. The likelihood for subsequent diabetes increases when GDM is diagnosed in early pregnancy and when maternal fasting glucose levels are elevated. Presumably, some of these women with impaired β-jail cell office may stand for cases of unidentified preexisting type 2 diabetes.

As noted earlier, GDM is a state restricted to pregnant women whose impaired glucose tolerance (IGT) is discovered during pregnancy. Because in nigh cases, patients with GDM have normal fasting glucose levels, some challenge of glucose tolerance must be undertaken. In the past, obstetricians relied on historic and clinical risk factors to select those patients most likely to develop GDM. This group included patients with a family history of diabetes and those whose past pregnancies were marked by an unexplained stillbirth or the delivery of a malformed or macrosomic infant. Obesity, hypertension, glycosuria, and maternal age older than 25 years were other indications for screening. Although multiple risk factors may increment the likelihood of GDM, more one-half of all women who exhibit an abnormal GTT lack whatever of these risk factors.

The ACOG suggests that all meaning women be screened for GDM, whether by the patient's medical history, clinical risk factors, or laboratory screening tests to determine blood glucose levels (Box 45.two). Screening is generally performed at 24 to 28 weeks' gestation, when the "diabetogenic state" of pregnancy has been established. Boththe ADA and ACOG recommend early pregnancy screening for undiagnosed type two diabetes in women with a previous history of GDM, women who have delivered an infant weighing 4000 g or more, women with a history of impaired glucose metabolism or cardiovascular illness, those who are overweight or obese (BMI ≥25), women with a history of hypertension or polycystic ovary syndrome or a kickoff-degree relative with diabetes, and members of high-adventure race or ethnicity groups as noted previously. Withal, studies validating various approaches to early pregnancy screening for both type 2 diabetes and GDM are lacking. A simple approach to early screening for diabetes is to obtain an HbA1c level in women believed to be at greatest run a risk. A diagnosis of overt diabetes is made if the level is greater than or equal to 6.v%. In these women who may accept had diabetes during embryogenesis, a comprehensive ultrasound should exist performed afterwards in pregnancy to detect fetal malformations. If the level is betwixt 5.seven% and 6.iv%, suggesting IGT, a diagnostic oral GTT is performed. Fong and colleagues have reported that 25 percent of these women volition subsequently develop GDM. For those women with normal results or those with an HbA1c level less than 5.vii%, screening for GDM is so undertaken at 24 to 28 weeks. Recently, Hughes and colleagues 44 suggested that an early HbA1c level greater than or equal to 5.ix% is optimal for detecting overt diabetes in women at less than 20 weeks' gestation and likewise identifies women at increased take a chance of adverse pregnancy outcomes.

Carbohydrate Metabolism and Its Diseases

J. Jerry Kaneko , in Clinical Biochemistry of Domestic Animals (Sixth Edition), 2008

5 Glucose Tolerance and the Insulin Response

The glucose tolerance examination (GTT) is the most of import test of carbohydrate role and is of detail value in those cases of diabetes in which the fasting blood glucose is merely moderately elevated and the diagnosis is equivocal (Section VIII.C). The diabetic oral GGT bend is high and relatively flat, indicating a decreased tolerance for glucose ( Fig. 3-12). The nature of the diabetic curve tin exist quantitated by using the intravenous GTT. The diabetic curve is characterized by a long T1/2 or low k-value, which reflects the inability of the animal to employ the test dose of glucose. The insulin response bend in type I (absolute insulin deficiency) diabetes clearly demonstrates the disability of the pancreas to release insulin in response to the glucose load. It is in the absence of an insulin response, which is responsible for the failure of the diabetic to use the added glucose, that the prolonged hyperglycemia occurs. An important factor adding to the hyperglycemia is the overproduction of glucose by the liver. The exam dose of glucose is in result added to the already existing oversupply of glucose. Because the steady-state level at which the liver ceases to supply or remove glucose is elevated in diabetes, the liver continues to oversupply glucose, which contributes to the slow return of the tolerance curve to its original level.

In types II and Iii diabetes (come across the post-obit discussion), in that location is also glucose intolerance, but this occurs in the presence of a normal to elevated insulin. This would mean that the insulin in the plasma of these types is unusable or ineffective (i.e., relative deficiency) because of a number of factors including insufficient receptors, receptor blockage, abnormal receptor structure, or antibody binding, all of which lead to the glucose intolerance and the phenomenon of insulin resistance. Therefore, glucose intolerance is seen in all types of diabetes whether at that place is an absolute (type I) or relative (types Ii, Three) deficiency of insulin. The insulin response must be evaluated in order to establish the type of diabetes.

Read full affiliate

URL:

https://www.sciencedirect.com/scientific discipline/article/pii/B9780123704917000039

Diabetes in Pregnancy

Robert Resnik Physician , in Creasy and Resnik's Maternal-Fetal Medicine: Principles and Do , 2019

Gestational Diabetes

GDM is defined equally glucose intolerance diagnosed during pregnancy that is not clearly preexisting diabetes. The underlying pathophysiology of GDM in virtually instances is like to that observed for T2DM: an inability to maintain an adequate insulin response because of the significant decreases in insulin sensitivity with advancing gestation.

It is estimated that v% to 9% of pregnant women will exist diagnosed with GDM using the standard two-footstep procedure based on the 100-m, 3-hr OGTT. 19 This is not surprising, because GDM is the precursor to T2DM, based on ethnicity-specific increases in insulin resistance and rising obesity in women of reproductive age. Clinical recognition of GDM is important considering therapy can reduce pregnancy complications and potentially reduce long-term sequelae in the offspring.

The use of the 3-hour, 100-g OGTT for diagnosis of GDM was based on John O'Sullivan'south work in the 1960s. 20 O'Sullivan established criteria for the OGTT that served as a risk predictor for development of T2DM afterwards the pregnancy; however, the limits for the iii-hr 100-one thousand OGTT were divers to yield a group of women in the top 98th percentile of glucose response. Other problems with use of the 3-hour OGTT—including the propensity for patient emesis after such a large glucose load, which invalidated the test—led to the development of the 2-stride testing regimen used widely in the United States, which involves a 50-g "challenge" pretest followed by the 100-g OGTT but if the initial result is abnormal. However, the 2-step diagnostic system inherently imposes delay in diagnosis of GDM and has a relatively loftier false-negative charge per unit (ten% to twenty%).

In 2010, the International Association of Diabetes and Pregnancy Study Groups (IADPSG) recommended new criteria for the diagnosis of GDM. 21 These criteria (Box 59.ii andTable 59.1) are based on the results of a big (25,000 participants) multinational observational trial known as the Hyperglycemia and Agin Pregnancy Outcome (HAPO) study, 22 which meticulously tracked adverse pregnancy and neonatal outcomes. The new IADPSG criteria were based primarily on the risks of excessive agin perinatal outcomes (odds ratios [ORs] >ane.75) for newborn nascence weight, body fatty, and string C-peptide level, adjusted for confounding variables.

The new IADPSG criteria for GDM diagnosis have been adopted widely globally (by the World Wellness Organization) only notably with limitations in the Us by the ADA, 13 and not by the American College of Obstetricians and Gynecologists (ACOG), 23 largely considering of the substantial increase in women diagnosed with GDM—up to 18% using the new criteria, compared to five% to 10% with the 2-step 3-hour OGTT organization—without clear testify of benefit.

Hypothalamic, pituitary and adrenal disorders

Miles J. Levy , Trevor A. Howlett , in Clinical Biochemistry: Metabolic and Clinical Aspects (Third Edition), 2014

Glucose tolerance examination

The 75 g glucose tolerance test (GTT) remains the gold standard test for the diagnosis of acromegaly. After glucose, plasma GH in normal individuals is suppressed to <0.4  μg/L. Patients with acromegaly fail to show consummate suppression and may show a paradoxical rising of plasma GH. Failure of GH to autumn to <0.4   μg/L is highly suggestive of acromegaly, even if substantial suppression of GH has occurred, and an elevated IGF-1 will normally confirm the diagnosis.

Failure of normal glucose suppression of GH may occur in the absence of acromegaly in liver affliction, poorly controlled diabetes, chronic kidney illness, malnutrition (including anorexia nervosa) and primary growth hormone insensitivity (Laron syndrome). Diabetes tin can be a particular diagnostic challenge, since a GTT is inappropriate in established disease. Insulin-similar growth factor ane concentrations, however, are typically normal in uncomplicated diabetes, and, if elevated, the authors usually recommend a four-point GH day curve to ostend circulating GH concentrations consistently in a higher place the 'safe' range.

Read full chapter

URL:

https://www.sciencedirect.com/scientific discipline/commodity/pii/B9780702051401000183

Blazon i Diabetes Mellitus

Shlomo Melmed MB ChB, MACP , in Williams Textbook of Endocrinology , 2020

Diagnosis

A diagnosis of diabetes has historically included an elevated fasting blood glucose level, any glucose value higher than 200 mg/dL (11 mmol/Fifty) with symptoms of hyperglycemia, or an abnormal 2-hour oral glucose tolerance test (OGTT). 9 American Diabetes Clan (ADA) guidelines for the diagnosis of diabetes were modified in 2009 to include a hemoglobin A1c (HbA1c) value greater than 6.5%. 10 Under certain settings (east.yard., obesity, racial status other than Caucasian) and particularly among adults, the diagnosis of T1DM versus type ii diabetes mellitus (T2DM) can evidence quite challenging. At present, the best criterion for separating the two disorders resides in laboratory identification of any one of a number of islet prison cell autoantibodies (also known as T1DM-associated autoantibodies; i.east., anti-insulin autoantibodies [IAA], anti–glutamic acid decarboxylase [GADA], anti–insulinoma-associated antigen 2 [IA2A], or anti-zinc-transporter eight [ZnT8A]). Literally hundreds of studies over the past three decades accept suggested that the presence of these autoantibodies provides high sensitivity for diagnosing persons with T1DM. 11 Indeed, more than ninety% of Caucasian children presenting with diabetes express at least ane of these four T1DM-associated autoantibodies. 12 In terms of disease specificity, T1DM-associated autoantibodies are typically positive in less than 1% to 2% of unaffected (i.east., non-T1DM) individuals, farther validating their diagnostic utility. Notwithstanding, amongst African-American and Latino children and adolescents in the United states of america diagnosed with diabetes, almost one half lack any T1DM-associated autoantibody. Many patients from these ethnic minorities in the United States present clinically every bit if they have early-onset T2DM (east.g., mild ketosis, slow symptomatic onset), some accept bellboy risk factors such as obesity, and many lack man leukocyte antigen (HLA) alleles associated with T1DM. Increasingly diverse genetic admixtures, due to geographic migration and social changes (e.g., multiracial offspring), further contribute to diagnostic complexity.

In childhood and adolescence, two peaks of T1DM presentation occur: a smaller peak between v and 7 years of age and a larger peak at or near puberty. 13 Although most autoimmune disorders disproportionately target females, T1DM affects males slightly more than females. The incidence of T1DM varies with seasonal changes and birth calendar month. Incidence of T1DM diagnosis is higher in autumn and winter, whereas being born in the bound is associated with an increased likelihood for T1DM. 14 Interestingly, the development of T1DM-associated autoimmunity (i.e., the formation of islet autoantibodies) in the months to years prior to the onset of symptomatic T1DM also shows a degree of seasonal synchronization.

The measurement and presence of T1DM-associated autoantibodies have too fueled much debate regarding the percentage of T1DM cases that are errantly misclassified as T2DM. Indeed, it is conceivable that 5% to xv% of adults diagnosed with T2DM may have T1DM, given the frequency of T1DM-associated autoantibodies in populations diagnosed with T2DM. xv This is, in outcome, a trouble in wellness intendance provider recognition of the potential for T1DM disease in adult populations combined with a lack of widespread screening for such autoantibodies in settings in which screening would seem warranted. If this exclamation is correct, given the vastly greater number of persons diagnosed with T2DM (relative to that of T1DM), the number of actual T1DM cases in a given population may be massively underestimated. This is therapeutically unfortunate because an accurate diagnosis of T1DM is vital; persons misdiagnosed as having T2DM when they indeed have T1DM experience higher HbA1c, take risk of diabetic ketoacidosis (DKA) due to apply of noninsulin therapies, and have accelerated progression toward micro- and macrovascular complications..

The Role of the Skin in Saccharide Metabolism

John A. Johnson , Ramon M. Fusaro , in Advances in Metabolic Disorders, 1972

two Technique

Functioning of the CutGTT has been described in detail (Fusaro and Johnson, 1965) and volition be outlined only briefly hither. The exam is an extension of the IVGTT, with the boosted characteristic that skin glucose concentration is likewise monitored. Triplicate blood and peel specimens were obtained from a fasting subject, and 35 gm of glucose was administered intravenously. At appropriate intervals blood specimens were nerveless and lysed in xxx vol of water. Too, skin specimens were obtained from the back with a motor-driven, iii-mm rotary punch, quickly weighed, and immersed in 1% aqueous ZnSOiv. After 1.5 hours, an equimolar quantity of 0.06 N Ba(OH)2 was added to each specimen, and the mixtures were centrifuged. The four aliquots obtained from each articulate supernatant fluid were employed in two separate glucose assays (in indistinguishable), with glucose oxidase reagent. Blood samples were depro-teinized with 0.3 N Ba(OH)2 and v% ZnSOfour, and aliquots were assayed with the microvolumetric procedure employed for skin. Excess blood and skin glucose values were calculated past subtracting boilerplate fasting glucose from the postinjection levels. The plots of logarithm excess glucose versus postinjection time were fitted with directly lines past the method of least squares; and from the slopes of the corresponding lines a disappearance rate constant (percentage per minute) for blood glucose and for skin glucose was calculated.

Read total chapter

URL:

https://world wide web.sciencedirect.com/scientific discipline/article/pii/B9780120273065500061

Insulin Resistance and the Metabolic Syndrome

Edward (Lev) Linkner Medico , Corene Humphreys ND , in Integrative Medicine (Quaternary Edition), 2018

Diagnosis

Metabolic syndrome tin can be diagnosed using the criteria described in Table 32.ane . Exterior a research laboratory, standard of practice for the diagnosis of the metabolic syndrome is to behave a 2-hr glucose and insulin tolerance test (GITT), which tin can easily be ordered through any outpatient laboratory. The protocol is as follows: (1) ii days of carbohydrate loading, (2) blood sampling for fasting glucose and insulin measurements, and (3) consumption of a 75-g glucose drink. Thereafter, blood specimens for glucose and insulin measurements are obtained (but not e'er necessarily) at one-half-hour intervals for the first hour, followed by a final specimen two hours later. In the majority of patients, fasting and ii-hour measurements are sufficient. Essentially, this protocol is the standard glucose tolerance examination (GTT) with concomitant insulin testing. A caveat of this arroyo is that clinicians should ensure the laboratory used is familiar with diagnostic procedures involving insulin, which is a very unstable hormone in vitro. False-negative diagnoses are possible if just a fasting insulin specimen is obtained. Regular drawing of blood specimens for the measurement of insulin is required to maintain test functionality. Clinician are required to understand the issue of insulin on managing blood glucose levels following glucose consumption. Baseline fasting insulin levels should ordinarily be less than 15 microunits/mL and less than 30 microunits/mL at 2 hours post-obit consumption of a 75-1000 glucose load.

Although the 2-hour GITT is considered the nearly accurate and functional test, other methods for the diagnosis of the metabolic syndrome include the post-obit:

•

Triglyceride-to-HDL cholesterol ratio (TG:HDL-C)—a healthy ratio is less than 2.

•

Glycosylated hemoglobin (HbA1c): values for patients with IR are between 5.7 and 6.four as per the 2010 American Diabetes Clan guidelines. 63

•

Fasting insulin: When assessed in isolation, normal values should be less than 15 microunits/mL (140 pmol/L); however, a normal fasting insulin result does not rule out IR. Reference ranges are laboratory specific, and so clinicians must check with the clinical laboratories for specific values. In addition, what is "normal" and what is "healthy" can be vastly unlike.

Other markers of importance include elevated hs-CRP, uric acid, small dense low-density cholesterol (sd LDL-C), and inflammatory markers such as IL-6 and IL-8, TNF-alpha, PAF-1, and adiponectin. Because NAFLD is hypothesized to represent the hepatic manifestation of IR, the measurement of gamma-glutamyl transpeptidase (GGT) levels should besides be considered as this transaminase enzyme is the most sensitive in detecting liver toxicity.

For the bulk of clinicians, the 2-hour GITT is the virtually valuable in terms of diagnosis and patient didactics, especially for normal-weight individuals suspected to take metabolic syndrome and women with polycystic ovarian syndrome.

Read total chapter

URL:

https://world wide web.sciencedirect.com/scientific discipline/article/pii/B9780323358682000323

Functional Glycomics

Kazuaki Ohtsubo , in Methods in Enzymology, 2010

four Glucose and Insulin Homeostasis

Evaluating the glucose homeostasis by a glucose tolerance test is a office of a panel tests used to diagnose diabetes. Glucose tolerance test involves the administration of glucose, followed by monitoring how rapidly it is cleared from the claret and the simultaneous conclusion of the glucose-stimulated insulin secretion office of pancreatic β cells. To eliminate fluctuations in blood glucose levels by food intake, the mice must exist fasted prior to the administration of glucose.

Method for glucose tolerance test

1.

For administrating glucose at 1.five   one thousand/kg torso weight, the glucose solution should be prepared in PBS at a concentration of 300   mg/ml, equivalent to an injection of 100   μl for xx   g of body weight.

ii.

GnT-IVa mice and their littermate command mice are fasted for sixteen   h.

iii.

The mouse is speedily anesthetized by inhalation of mehoxyflurane to collect blood from the orbital sinus using a hematocrit capillary, followed by an intraperitoneal injection of glucose using an insulin syringe with a 28-gauge needle. Blood glucose levels can be readily measured by using a glucometer (One Touch on Ultra), in conjunction with a timer, to determine the fourth dimension from injection. In recently published guidelines for mouse protocols in many institutions, claret collection from the orbital sinus is prohibited.

iv.

At 30, 60, 120, and 240   min after the glucose injection, blood samples are collected in serum separator tubes (BD Microtainer) and blood glucose levels are measured at each time point, by the above process. Subsequently the blood becomes clotted at room temperature for 2   h, serum is separated by centrifugation at 3000×g for 5   min.

5.

Insulin levels in serum samples are determined using a mouse insulin ELISA kit (Crystal Chem).

GnT-IVa-deficient mice exhibit an aberrant response in a glucose tolerance exam, yielding blood glucose levels that are essentially and persistently elevated, which is consistent with the absence of insulin secretion responses upon a glucose challenge ( Fig. 12.iii). This suggests that GnT-IVa-deficient mice accept a defect in the insulin secretion machinery in pancreatic β cells.

Figure 12.3. Glucose tolerance exam. Glucose solution is injected into fasted mice at time betoken 0 and blood samples are collected at the indicated intervals later injection. (A) Blood glucose levels in wild-type (white circles) and Mgat4a goose egg (blackness circles) littermates (n  =   10; ***p  &lt;   0.0001). (B) Serum insulin levels measured during the glucose tolerance test (n  =   10; ***p  &lt;   0.0001).

 Partly adapted from Ohtsubo et al. (2005).

Read full chapter

URL:

https://www.sciencedirect.com/science/article/pii/S0076687910790121

High-chance pregnancies

Zita West SRN SCM LIC AC , ... Lyndsey Isaacs RGN BSc(Hons) MBAcC , in Acupuncture in Pregnancy and Childbirth (Second Edition), 2008

Diabetes

Diabetes is a medical condition in which the pancreas fails to produce sufficient insulin. Although the result is mainly seen in relation to glucose metabolism, most of the metabolic pathways are disturbed and the affliction affects all the systems of the trunk. Perinatal complications and mortality are increased.

Types of diabetes

Insulin dependent

The patient volition have an aberrant glucose tolerance examination and an well-nigh consummate lack of insulin. The symptoms are meaning (including excessive urination and dehydration) and treatment is required. Information technology is well-nigh common in juveniles.

Not-insulin dependent

The patient will have abnormal glucose tolerance exam but no symptoms. It is more frequent in later life and among those who are obese.

Gestational diabetes

A woman can develop glucose intolerance during pregnancy due to dumb insulin secretion and action. It is generally treated past nutrition and insulin therapy. Contempo studies have shown that gestational diabetes has increased aslope the rise of general obesity around the Western world. Although investigations are ongoing, some studies have shown that untreated gestational diabetes has been linked to an increased gamble of obesity and diabetes of those children as young adults. Lifestyle changes and the use of oral medication are at present beingness looked at as less costly treatment (Catalano et al 2003, Metzger 2006, Svare et al 2001).

Read full chapter

URL:

https://www.sciencedirect.com/science/article/pii/B9780443103711500110

PANCREAS

Margaret E. Smith PhD DSc , Dion M. Morton Md DSc , in The Digestive System (Second Edition), 2010

The blood tests showed increased bilirubin and alkali metal phosphatase. The glucose tolerance test showed an abnormally loftier and prolonged rising in serum glucose, and urine analysis confirmed the presence of glucose (glycosuria), indicating that the patient was diabetic. The presumptive diagnosis was chronic pancreatitis. The patient was prescribed pethidine to control the pain. He was advised to abstain completely from booze, and to eat regular meals. Figure five.2 shows a CT (computerized tomography) scan of the abdomen of an private with chronic pancreatitis. The swollen pancreas can be clearly seen. Test of the details of this case gives rise to the post-obit questions:

•

Is the primary defect in chronic pancreatitis known?

•

What might the 10-ray accept revealed?

•

What could be the cause of the condition in this patient?

•

How are the exocrine and endocrine functions of the pancreas impaired in chronic pancreatitis?

•

What did the high faecal fat content indicate?

•

What is the basis of the glucose tolerance test and why has diabetes mellitus developed in this patient?

•

Why did the patient appear jaundiced?

•

Why were the patient'southward serum bilirubin and alkaline phosphatase abnormally loftier?

•

What are the chief physiological consequences of this disease and how tin the status be treated or managed?

Read full affiliate

URL:

https://www.sciencedirect.com/science/commodity/pii/B9780702033674000050